Fátima Bosch Selected Research

1-phosphofructokinase

8/2009

Phosphofructo-1-kinase deficiency leads to a severe cardiac and hematological disorder in addition to skeletal muscle glycogenosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fátima Bosch Research Topics

Disease

2	Retinitis Pigmentosa (Pigmentary Retinopathy) 04/2022 - 09/2008
2	Fibrosis (Cirrhosis) 10/2020 - 01/2018
2	Inflammation (Inflammations) 01/2019 - 01/2018
1	Down Syndrome (Down's Syndrome) 01/2019
1	Insulin Resistance 01/2019
1	Obesity 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018
1	AIDS-Related Complex (ARC) 02/2015
1	Body Weight (Weight, Body) 02/2015
1	Glycogen Storage Disease Type VII (Tarui's Disease) 08/2009
1	Glycogen Storage Disease (Glycogenosis) 08/2009
1	Blindness (Hysterical Blindness) 09/2008

Drug/Important Bio-Agent (IBA)

2	ProinsulinIBA 04/2022 - 09/2008
1	Insulin ReceptorIBA 04/2022
1	CollagenIBA 10/2020
1	EndocannabinoidsIBA 01/2019
1	Dyrk KinasesIBA 01/2019
1	CannabinoidsIBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	transgelinIBA 01/2019
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 02/2015
1	Cocaine (Cocaine HCl)IBA 02/2015
1	NeuropeptidesIBA 02/2015
1	MelanocortinsIBA 02/2015
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 02/2015
1	Amphetamine (Amfetamine)FDA LinkGeneric 02/2015
1	1-phosphofructokinaseIBA 08/2009
1	EnzymesIBA 08/2009
1	Glucose (Dextrose)FDA LinkGeneric 08/2009
1	Retinaldehyde (Retinal)IBA 09/2008

Therapy/Procedure

2	Therapeutics 08/2009 - 09/2008
1	Aftercare (After-Treatment) 01/2018